View : 310 Download: 0
Effects of single nucleotide polymorphisms in c-Myc on stable warfarin doses in patients with cardiac valve replacements
- Effects of single nucleotide polymorphisms in c-Myc on stable warfarin doses in patients with cardiac valve replacements
- Lee, Kyung E.; Chang, Byung C.; Park, Sunny; Gwak, Hye S.
- Ewha Authors
- SCOPUS Author ID
- Issue Date
- Journal Title
- PHARMACOGENOMICS vol. 16, no. 10, pp. 1101 - 1108
- 8q24; c-Myc; transcription factor; VKORC1; warfarin
- FUTURE MEDICINE LTD
- SCIE; SCOPUS
- Document Type
Show the fulltext
- This study aimed to investigate an association between c-Myc SNPs and stable warfarin doses. Materials & methods: The influences of genetic polymorphisms on dose requirements were investigated by genotyping ten SNPs in 201 patients with stable warfarin doses; VKORC1 (rs9923231), CYP2C9 (rs1057910), CYP4F2 (rs2108622), GATA4 (rs10090884), c-Myc (rs4645962, rs4645943, rs4645948 and rs4645974) and 8q24 (rs1447295 and rs16901979). Results: Around 44.3% of the overall interindividual variability in warfarin dose requirements was explained by the multivariate regression model; VKORC1 genotype accounted for 26.4%, CYP2C9 genotype for 4.9%, age for 3.4%, c-Myc genotypes for 5.2% (rs4645974 for 2.4% and rs4645943 for 2.8%), CYP4F2 genotype for 2.9% and diuretic use for 1.5%. Conclusion: Our results revealed that c-Myc could be a determinant of stable warfarin doses.
- Appears in Collections:
- 약학대학 > 약학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.